Skip to main content

Table 1 Baseline characteristics of participating physicians

From: Effectiveness of educational outreach visits compared with usual guideline dissemination to improve family physician prescribing—an 18-month open cluster-randomized trial

 

Intervention

Control

Physicians per cluster—mean (standard deviation)

6.3 (1.4)

6.3 (1.4)

Unit type—n units (n physicians)

 Family health unit

17 (107)

18 (114)

 Personalized care unit

2 (13)

1 (5)

Female, %

70.8

79.0

Age—years, median (P25P75)

52 (41–59)

47 (38–59)

Years in practice—median (P25P75)

13 (6.5–28)

11 (4–28)

Residency tutor, %

55.8

52.9

Patient list size—median (P25P75)

1874 (1812–1923)

1813 (1746–1872)

Prescription—mean (standard deviation)

 Omeprazole, %

47.13 (13.50)

48.30 (13.70)

 COX-2 inhibitors, %

13.20 (9.69)

14.67 (12.88)

 Clopidogrel, DDD/1000 patients

0.0986 (0.0502)

0.1053 (0.0491)

NHS expenditure with NSAIDs, acid secretion modifiers, and clopidogrel/month/1000—€, mean (standard deviation)

189.60 (73.41)

192.72 (85.67)

  1. P25, first quartile, P75 third quartile, COX-2 cycloxigenase-2, DDD defined daily dose, NHS National Health Service, NSAIDs non-steroidal anti-inflammatory drugs